1. Home
  2. PEN vs FN Comparison

PEN vs FN Comparison

Compare PEN & FN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • FN
  • Stock Information
  • Founded
  • PEN 2004
  • FN 1999
  • Country
  • PEN United States
  • FN Cayman Islands
  • Employees
  • PEN N/A
  • FN N/A
  • Industry
  • PEN Medical/Dental Instruments
  • FN Telecommunications Equipment
  • Sector
  • PEN Health Care
  • FN Utilities
  • Exchange
  • PEN Nasdaq
  • FN Nasdaq
  • Market Cap
  • PEN 9.1B
  • FN 8.3B
  • IPO Year
  • PEN 2015
  • FN 2010
  • Fundamental
  • Price
  • PEN $268.17
  • FN $252.29
  • Analyst Decision
  • PEN Buy
  • FN Buy
  • Analyst Count
  • PEN 16
  • FN 8
  • Target Price
  • PEN $262.87
  • FN $255.63
  • AVG Volume (30 Days)
  • PEN 423.0K
  • FN 393.1K
  • Earning Date
  • PEN 02-20-2025
  • FN 02-03-2025
  • Dividend Yield
  • PEN N/A
  • FN N/A
  • EPS Growth
  • PEN N/A
  • FN 25.19
  • EPS
  • PEN 0.89
  • FN 8.45
  • Revenue
  • PEN $1,163,776,000.00
  • FN $3,001,718,000.00
  • Revenue This Year
  • PEN $13.55
  • FN $18.42
  • Revenue Next Year
  • PEN $14.48
  • FN $13.18
  • P/E Ratio
  • PEN $302.85
  • FN $29.86
  • Revenue Growth
  • PEN 16.96
  • FN 12.20
  • 52 Week Low
  • PEN $148.00
  • FN $159.69
  • 52 Week High
  • PEN $277.34
  • FN $278.38
  • Technical
  • Relative Strength Index (RSI)
  • PEN 68.37
  • FN 64.47
  • Support Level
  • PEN $237.65
  • FN $216.78
  • Resistance Level
  • PEN $260.88
  • FN $240.51
  • Average True Range (ATR)
  • PEN 9.75
  • FN 7.57
  • MACD
  • PEN 2.18
  • FN 3.04
  • Stochastic Oscillator
  • PEN 94.76
  • FN 99.01

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

About FN Fabrinet

Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

Share on Social Networks: